Metis Global Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Metis Global Partners's DXCM Position: Q2 2026 in Review
Metis Global Partners reduced its DexCom (DXCM) stake by 16% in Q2 2026, selling an estimated $119K and leaving 9,262 shares worth $624K. The position accounts for 0.01% of the portfolio, ranked #527.
Metis Global Partners first reported a position in DXCM in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.52M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Metis Global Partners held 9,262 shares of DexCom worth $624K as of Q2 2026.
- Metis Global Partners sold 1,781 DexCom shares in Q2 2026, an estimated $119K.
- DexCom made up 0.01% of Metis Global Partners's portfolio in Q2 2026, its #527 holding.
- Metis Global Partners first reported a position in DexCom in Q4 2021 and has held it in 19 quarters since.
- Metis Global Partners's DexCom position peaked at $2.52M in Q1 2024.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.